Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Inulin for Intestinal Health in Cystic Fibrosis
NCT04118010Phase 4Completed
- Sponsor
- Emory University
- Start
- Mar 2020
- Primary completion
- Dec 2022
- Modality
- Microbiome Therapeutics, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d and inulin in cystic fibrosis (CF) and dysbiosis (4 arms), sponsored by Emory University. Primary endpoints: Shannon Index at 12 weeks and Species Richness Index at 12 weeks. Started Mar 2020; status: completed.
02
Drugs
vitamin dinulin
03
Conditions
cystic fibrosis (CF)dysbiosis
Beyond the preview
Go deeper on NCT04118010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118010.